At close: December 20 at 4:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | 0.58 | -0.81 |
| Low Estimate | 0 | 0 | 0.58 | -0.81 |
| High Estimate | 0 | 0 | 0.58 | -0.81 |
| Year Ago EPS | -- | -- | -0.57 | 0.58 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 4 |
| Avg. Estimate | -- | -- | 98.33M | 50.03M |
| Low Estimate | -- | -- | 97M | 21M |
| High Estimate | -- | -- | 99.3M | 66.8M |
| Year Ago Sales | -- | -- | 38.18M | 98.33M |
| Sales Growth (year/est) | -- | -- | 157.58% | -49.12% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0.58 | -0.81 |
| 7 Days Ago | 0 | 0 | 0.58 | -0.81 |
| 30 Days Ago | 0 | 0 | 0.58 | -0.81 |
| 60 Days Ago | 0 | 0 | 0.51 | -0.51 |
| 90 Days Ago | 0 | 0 | 0.51 | -0.51 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GNFT | -- | -- | 201.77% | -239.66% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/29/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 6/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2024 |
Related Tickers
QUIA.ST Quia Pharma AB (publ)
0.0172
+3.61%
DIABIO.ST Diagonal Bio AB (publ)
0.0258
+5.31%
ZICC.ST Ziccum AB (publ)
0.3830
-6.36%
CRNA.OL Circio Holding ASA
0.7080
-3.28%
FLUI.ST Fluicell AB (publ)
0.0412
-1.90%
ZIVO ZIVO Bioscience, Inc.
19.00
+5.56%
ISOFOL.ST Isofol Medical AB (publ)
2.4050
-3.80%
ONCO.ST Oncopeptides AB (publ)
1.5080
-1.69%
CANTA.ST Cantargia AB (publ)
1.8490
+0.76%
KTTA Pasithea Therapeutics Corp.
2.6300
-1.50%